a capsule containing 5-meo-dmt courtesy the DEA's Microgram The Pennsylvania State Police Crime Laboratory in Lima, Pennsylvania, recently received a poly-drug submission consisting of: A) 42 round green tablets marked with the Batman logo on one face and half-scored on the reverse face, suspected MDMA (see Photo 5); B) 20 round white tablets marked with “G.” on one face and a reclining woman logo on the reverse face, suspected MDA (see Photo 6); C) Four squares of white blotter paper, suspected LSD (no photo); D) Two bags of white powder, submitted as an unknown (no photo); and E) 29 clear capsules containing white or off-white solids, also submitted as an unknown. The exhibits were seized in three separate but related operations in Upper Darby Township (near Philadelphia) by the Upper Darby Township Police (no further details). Analysis of the green tablets (total net mass 14.9 grams) by GC/MS, however, indicated not MDMA but rather a 1 : 1 mixture of caffeine and 3,4-methylenedioxymethylnitrostyrene (an intermediate in the synthesis of MDA or 3,4-methylenedioxyphenyl-2-propanone). When tested with the Marquis reagent, the samples from the green tablets turned black, but the color did not spread into the liquid. Analysis of the white tablets (total net mass 6.2 grams) by Marquis and GC/MS confirmed MDA (not quantitated). Analysis of the blotter paper by Ehrlich’s and GC/MS confirmed LSD (not quantitated). Analysis of the first bag of powder (total net mass 0.53 grams) by GC/MS and IR indicated ketamine (not quantitated). However, analysis of the second bag of powder (total net mass 0.21 grams) by GC/MS and microcrystal testing indicated dextromethorphan (not quantitated). Analysis of the capsules by GC indicated four different drugs: 1) 19 capsules (total net mass 0.95 grams) contained 2,5-dimethoxy-4-ethylamine (2C-E, not quantitated, see Photo 7 (Photos 7 - 10 next page)); 2) six capsules (total net mass 0.71 grams) contained 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT, also known as Foxy-Methoxy, not quantitated, see Photo 8); 3) three capsules (total net mass 0.36 grams) contained 2,5-dimethoxy-4-bromophenethylamine (2C-B, also known as Nexus, not quantitated, see Photo 9); and 4) one capsule (total net mass 0.10 grams) contained 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT, not quantitated, see Photo 10). This was the first submission of 5-MeO-DIPT, 5-MeO-DMT, 2C-B, 2C-E, and 3,4-methylene-dioxymethylnitrostyrene to the laboratory. The large variety of drugs in this case was unusual.